Cerenome, Inc. (CNSY)
0.6427
-0.03
(-4.06%)
USD |
NASDAQ |
Nov 06, 16:00
0.6601
+0.02
(+2.71%)
After-Hours: 20:00
Cerenome Free Cash Flow : -23.55M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.55M |
| March 31, 2026 | -21.72M |
| December 31, 2025 | -20.84M |
| September 30, 2025 | -15.78M |
| June 30, 2025 | -16.90M |
| March 31, 2025 | -12.87M |
| December 31, 2024 | -11.24M |
| September 30, 2024 | -11.95M |
| June 30, 2024 | -10.66M |
| March 31, 2024 | -11.67M |
| December 31, 2023 | -13.01M |
| September 30, 2023 | -13.33M |
| June 30, 2023 | -15.18M |
| March 31, 2023 | -15.17M |
| December 31, 2022 | -13.48M |
| September 30, 2022 | -13.87M |
| June 30, 2022 | -11.92M |
| March 31, 2022 | -11.54M |
| December 31, 2021 | -10.42M |
| September 30, 2021 | -11.07M |
| June 30, 2021 | -10.68M |
| March 31, 2021 | -10.10M |
| December 31, 2020 | -8.527M |
| September 30, 2020 | -4.27M |
| June 30, 2020 | -4.477M |
| Date | Value |
|---|---|
| March 31, 2020 | -4.21M |
| December 31, 2019 | -5.973M |
| September 30, 2019 | -9.443M |
| June 30, 2019 | -10.02M |
| March 31, 2019 | -11.21M |
| December 31, 2018 | -12.11M |
| September 30, 2018 | -13.86M |
| June 30, 2018 | -15.39M |
| March 31, 2018 | -17.81M |
| December 31, 2017 | -19.62M |
| September 30, 2017 | -19.49M |
| June 30, 2017 | -19.91M |
| March 31, 2017 | -20.46M |
| December 31, 2016 | -19.60M |
| September 30, 2016 | -20.07M |
| June 30, 2016 | -21.63M |
| March 31, 2016 | -21.00M |
| December 31, 2015 | -21.09M |
| September 30, 2015 | -21.43M |
| June 30, 2015 | -22.79M |
| March 31, 2015 | -27.16M |
| December 31, 2014 | -31.35M |
| September 30, 2014 | -35.90M |
| June 30, 2014 | -36.50M |
| March 31, 2014 | -35.11M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals, Inc. | 752.13M |
| Ernexa Therapeutics, Inc. | -8.878M |
| ACADIA Pharmaceuticals, Inc. | -- |
| Anika Therapeutics, Inc. | 0.562M |
| Savara, Inc. | -110.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.132M |
| Cash from Investing (Quarterly) | 5.366M |
| Cash from Financing (Quarterly) | 1.11M |
| Free Cash Flow Per Share (Quarterly) | -1.106 |
| Free Cash Flow to Equity (Quarterly) | -6.95M |
| Free Cash Flow to Firm (Quarterly) | -7.626M |
| Free Cash Flow Yield | -626.6% |